BACE1 and Alzheimer disease: In contrast, a previous longitudinal study on a 2-year follow-up on platelets showed low BACE1 discriminator value for individuals who converted from MCI to AD, with an AUC of 0.64 (p = 0.04)(McGuinness et al., 2015).